US Court Strikes Down FDA’s Indication-Specific View of Orphan Exclusivity in Neurelis v Brenner
A US court has ruled against the FDA's indication-specific approach to orphan exclusivity, sparking debate…
Pharmaceuticals
Pfizer’s Q2 Results Reveal Significant Sales Growth, Boosts Profit Forecast for 2025
Pfizer's Q2 sales jump to $14.65 billion, driven by strong demand for its pharmaceutical products,…
Pfizer’s Financial Results Exceed Wall Street Expectations, Boosting Investor Confidence
Pfizer's latest financial results have surpassed Wall Street expectations, driven by strong sales of its…
Revolutionizing Healthcare: Rpharmy Unveils Groundbreaking Hazardous Drug Risk Initiative
Rpharmy to showcase innovative hazardous drug risk initiative at Florida Society of Health System Pharmacists…
Nefecon R Receives NMPA Approval for Production Expansion, Revolutionizing Treatment Options
Nefecon R, a groundbreaking medication, has received approval from the NMPA for production expansion, marking…
Biomark Diagnostics Inc. Expands Specialty Laboratory Services in Quebec to Meet Growing Demand
Biomark Diagnostics Inc. announces the expansion of its specialty laboratory services in Quebec to accommodate…
Pfizer Boosts Annual Profit Forecast Amidst Strong Pharmaceutical Sales
Pfizer increases annual profit forecast due to robust sales of its pharmaceutical products, driven by…
Pfizer Stock Soars: A $1,000 Investment Now Worth Over $114,500
A $1,000 investment in Pfizer stock 20 years ago would be worth over $114,500 today,…
US Healthcare Update: July 2025
The latest news and updates in the US healthcare sector for July 2025, covering regulatory…